Table 3.
Content of tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin 1 beta (IL-1β) and C-reactive protein (CRP) in rat serum.
| Groups | I | II | III | IV | V | VI |
|---|---|---|---|---|---|---|
| TNF-α (pg/mL) | 4.696 ± 0.582 | 15.794 ± 3.302a | 7.278 ± 1.076ab | 6.466 ± 1.138b | 9.462 ± 1.235ab | 12.518 ± 2.358ab |
| IL-6 (pg/mL) | 54.897 ± 9.348 | 76.801 ± 8.491a | 64.740 ± 5.291ab | 71.859 ± 7.800a | 73.387 ± 9.117a | 82.525 ± 9.874a |
| IL-1β (pg/mL) | 34.839 ± 9.561 | 100.101 ± 13.150a | 52.525 ± 5.892ab | 30.520 ± 6.569b | 40.631 ± 11.507b | 94.327 ± 9.806a |
| CRP (pg/mL) | 0.218 ± 0.091 | 1.052 ± 0.079a | 0.269 ± 0.060b | 0.199 ± 0.062b | 0.329 ± 0.063ab | 0.502 ± 0.029ab |
Group I: control; Group II: model; Group III: pioglitazone; Group IV: high dose of TangGanJian (TGJ); Group V: middle dose of TGJ; Group VI: low dose of TGJ.
Data are expressed as mean ± standard deviation.
ap < 0.05 compared with the control group.
bp < 0.05 compared with the model group.